Alligator Bioscience AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
For the full year, sales was SEK 58.11 million compared to SEK 35.7 million a year ago. Revenue was SEK 61.9 million compared to SEK 37.14 million a year ago. Net loss was SEK 248.59 million compared to SEK 193.4 million a year ago. Basic loss per share from continuing operations was SEK 0.55 compared to SEK 0.88 a year ago. Diluted loss per share from continuing operations was SEK 0.55 compared to SEK 0.88 a year ago.